Scaffold Hopping

The fundamental principle is the bioisosteric replacement of a central molecular framework. Unlike simple analoging, which modifies peripheral substituents (R-groups), scaffold hopping targets the core ring system that defines the chemotype. The new scaffold must project critical pharmacophoric features—hydrogen bond donors/acceptors, hydrophobic moieties, and aromatic rings—into the same three-dimensional space as the original ligand to maintain target binding.

This method uses an abstract pharmacophore model—a spatial map of essential steric and electronic features—as a query to search 3D databases. The original scaffold is discarded entirely; only the arrangement of features required for activity is retained. Key steps include:

• Generating a pharmacophore from the active ligand or receptor structure
• Excluding volumes that represent the receptor's steric boundary
• Screening conformer databases for molecules with a different scaffold that satisfy the feature constraints

Shape-based methods prioritize the global molecular shape and electrostatic potential over explicit chemical features. Algorithms like ROCS (Rapid Overlay of Chemical Structures) perform Gaussian volume overlaps to quantify shape Tanimoto (ShapeTanimoto) and color (electrostatic) similarity. This approach is agnostic to the underlying atom connectivity, enabling the identification of chemically distant but topologically similar scaffolds that occupy the same binding pocket volume.

Morphing algorithms iteratively transform one scaffold into another through a series of chemically valid intermediate structures. Techniques include:

• Ring opening/closure: Breaking or forming a ring to alter the core
• Ring contraction/expansion: Changing ring size (e.g., 6-membered to 5-membered)
• Heteroatom insertion: Replacing carbon with nitrogen, oxygen, or sulfur
• Atom-to-ring replacement: Replacing an acyclic atom with a cyclic system This generates a pathway of structurally related analogs, ensuring synthetic tractability.

Deep generative models, particularly Variational Autoencoders (VAEs) and Reinforcement Learning (RL) agents, are trained on large chemical libraries to propose novel scaffolds. The model learns a continuous latent representation of molecular structures. Scaffold hopping is achieved by:

• Encoding the active molecule into the latent space
• Navigating to a nearby region that corresponds to a different scaffold
• Decoding the new latent point into a valid SMILES string RL can further optimize the generated scaffolds for multi-parameter objectives like synthetic accessibility and predicted ADMET.

Successful scaffold hopping is validated by confirming that the new chemotype retains target engagement and functional activity. This often involves a feedback loop:

1. Computational proposal of a hopped scaffold
2. Synthesis of a focused library around the new core
3. Biophysical assay (e.g., SPR, X-ray crystallography) to confirm binding mode
4. Iterative refinement using structure-based design on the new scaffold This process transforms a hit from a known series into a genuinely novel lead series with a distinct structure-activity relationship (SAR) landscape.

The foundational concept underpinning scaffold hopping. A bioisostere is a chemical substituent or group with similar physical or chemical properties that produces broadly similar biological properties. Classic bioisosteres involve swapping a carboxylic acid for a tetrazole, while non-classical bioisosteres replace entire ring systems. Successful scaffold hopping identifies a novel core that acts as a non-classical bioisostere of the original scaffold, preserving the three-dimensional pharmacophore while altering the molecular framework.

A computational technique for defining the abstract spatial arrangement of steric and electronic features essential for target binding. A pharmacophore model distills the original active molecule down to a set of hydrogen bond donors/acceptors, hydrophobic centroids, and aromatic rings with defined distances and angles. Scaffold hopping algorithms search chemical libraries for novel cores that can present these identical features in the same 3D geometry, effectively decoupling the activity from the original scaffold.

A method for encoding a molecule's structure into a binary vector for computational comparison. While standard 2D fingerprints (like ECFP4 or MACCS keys) often fail to recognize scaffold hops due to low Tanimoto similarity, specialized 3D shape fingerprints and pharmacophoric fingerprints are designed to detect similarity between structurally distinct chemotypes. These fingerprints capture the volume overlap and feature distribution rather than the atom connectivity, enabling the identification of novel scaffolds with similar biological function.

The systematic navigation of the vast universe of synthetically feasible molecules to locate novel chemotypes. Scaffold hopping is a targeted form of chemical space exploration that constrains the search to regions with a high probability of retaining target activity. Techniques include:

• Enumeration of virtual libraries using robust chemical reactions
• Generative AI models trained to output valid SMILES strings with novel scaffolds
• Evolutionary algorithms that mutate and cross over molecular graphs while preserving a pharmacophoric constraint

A ligand-based approach that compares molecules based on the volume they occupy rather than their 2D structure. Algorithms like ROCS (Rapid Overlay of Chemical Structures) perform Gaussian-based volume overlap calculations to quantify how well a candidate scaffold mimics the shape of the reference molecule. This method is particularly effective for scaffold hopping because it is agnostic to the underlying atom connectivity, often identifying hops where a central phenyl ring is replaced by a saturated bicyclic system that fills the same spatial envelope.

A systematic cheminformatics approach that analyzes pairs of compounds differing by a single, well-defined structural transformation. In the context of scaffold hopping, MMPA databases can be mined to identify core replacements that have historically led to retained or improved activity across many targets. This knowledge-driven approach provides medicinal chemists with a ranked list of experimentally validated scaffold replacements, such as swapping an indole for an azaindole or a thiophene for a thiazole, along with the expected impact on potency and properties.